Gary Lu
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 33
- Acute Myeloid Leukemia Research 24
- Chronic Myeloid Leukemia Treatments 14
- Multiple Myeloma Research and Treatments 8
- Genetics 19
- Chronic Lymphocytic Leukemia Research 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Co-authors
- L. Jeffrey Medeiros (25 shared papers)Chung S. Yang (4 shared papers)Carlos E. Bueso‐Ramos (12 shared papers)C. Cameron Yin (15 shared papers)Hang Xiao (2 shared papers)Huanyu Jin (2 shared papers)Guang‐Yu Yang (2 shared papers)Jie Liao (2 shared papers)
- Journals
- American Journal of Clinical Pathology (4 papers)Blood (3 papers)Leukemia Research (3 papers)Annals of Oncology (2 papers)Modern Pathology (2 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Gary Lu
68 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 120
- Applied Microbiology and Biotechnology 70
- Hematology 383
- Pathology and Forensic Medicine 385
- Genetics 232
- Biochemistry 119
Countries citing papers authored by Gary Lu
This map shows the geographic impact of Gary Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Lu more than expected).
Fields of papers citing papers by Gary Lu
This network shows the impact of papers produced by Gary Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Lu. The network helps show where Gary Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 210 | |
| 2 | 2020 | 93 | |
| 3 | 2012 | 82 | |
| 4 | Population-based, case-control study of blood C-peptide level and breast cancer risk. | 2001 | 73 |
| 5 | Cancer prevention by tea and tea polyphenols. | 2008 | 60 |
| 6 | 2004 | 54 | |
| 7 | 2011 | 51 | |
| 8 | 2003 | 51 | |
| 9 | 2013 | 51 | |
| 10 | 2008 | 48 | |
| 11 | 2012 | 46 | |
| 12 | 2010 | 43 | |
| 13 | 2012 | 38 | |
| 14 | 2014 | 35 | |
| 15 | 2009 | 30 | |
| 16 | 2014 | 29 | |
| 17 | 2013 | 26 | |
| 18 | 2013 | 26 | |
| 19 | 2018 | 23 | |
| 20 | 2015 | 21 |
About Gary Lu
Gary Lu is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 69 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (8 papers), Multiple Myeloma Research and Treatments (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (70 citations), Hematology (383 citations), Pathology and Forensic Medicine (385 citations), Genetics (232 citations) and Biochemistry (119 citations). Gary Lu has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include L. Jeffrey Medeiros, Chung S. Yang, Carlos E. Bueso‐Ramos, C. Cameron Yin, Hang Xiao, Huanyu Jin, Guang‐Yu Yang, Jie Liao, Zhé Hóu and Mao-Jung Lee. Their work appears in journals such as American Journal of Clinical Pathology, Blood, Leukemia Research, Annals of Oncology and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.